PAUWELS ERIC (Chief Business Officer) sold 22.5% of their position (21.28K shares) of PTC THERAPEUTICS, INC. on the open market
Open‑market sale worth $1.60M — a significant reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 6/12/2026ACC: 0001323212-26-000010
Officer· Chief Business Officer
Since Apr 2020
-21.28K
Net shares
Net seller
$1.60M
Total sold
2
Open market trades
0B · 2S
4
Total transactions
17.57K acquired · 38.84K disposed
Non-Derivative Transactions3
Common Stock
Direct
Shares
−3.71K
Price / share
$75.00
Trade value
$278.32K
% of position
4.8%
6/10/2026
77.12K→73.41K
Common Stock
Direct
Shares
+17.57K
Price / share
$18.01
Trade value
$316.36K
% of position
23.9%
6/10/2026
73.41K→90.98K
Common Stock
Direct
Shares
−17.57K
Price / share
$75.00
Trade value
$1.32M
% of position
19.3%
6/10/2026
90.98K→73.41K
Total
Net shares
−3.71K
Net value
-$1.28M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/10/2026 | S · Sale | −3.71K | $75.00 | $278.32K | 4.8% | 77.12K | 73.41K |
| Common Stock Direct | 6/10/2026 | M · Option Exercise | +17.57K | $18.01 | $316.36K | 23.9% | 73.41K | 90.98K |
| Common Stock Direct | 6/10/2026 | S · Sale | −17.57K | $75.00 | $1.32M | 19.3% | 90.98K | 73.41K |
| Total | −3.71K | -$1.28M | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
17.57K shares
Shares
−17.57K
Strike price
18.01
Held after
0.00
Exercisable
—
6/10/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock17.57K shares | 6/10/2026 | S · Sale | −17.57K | 18.01 | — | 0.00 |